Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
1 drugs in development
By Therapeutic Area
top 1
R&D Momentum
63/100
Pipeline Velocity
41/100
Trial Completion Rate
100/100
Pipeline Concentration
50/100
Pipeline Freshness
90/100
Strategic Signals
Activity
Last 14 days
The Effect of De-epithelized Connective Tissue Graft Versus Sub-epithelized Connective Tissue Graft in Management of Thing Gingival Phenotype With Delayed Implants
Lactoferrin Nanohydrogel as a Therapeutic Adjunct for Enhancing Soft Tissue Healing and Implant Stability in Immediate Implant Placement. A Randomized Clinical Trial
Earlier
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)